Apoptosis is induced by caspases, which are members of the cysteine protease family 1 . Caspases are synthesized as inactive zymogens and initiator caspases first gain activity by associating with an oligomeric complex of their adaptor proteins, such as the apoptosome 2, 3 . Activated initiator caspases subsequently cleave and activate effector caspases. Although such a proteolytic cascade would predict that a small number of active caspases could irreversibly amplify caspase activity and trigger apoptosis, many cells can maintain moderate levels of caspase activity to perform non-apoptotic roles in cellular differentiation, shape change and migration 4 . Here we show that the Drosophila melanogaster apoptosome engages in a feedback inhibitory loop, which moderates its activation level in vivo. specifically, the adaptor protein Apaf-1 lowers the level of its associated initiator caspase Dronc, without triggering apoptosis. Conversely, Dronc lowers Apaf-1 protein levels. this mutual suppression depends on the catalytic site of Dronc and a caspase cleavage site within Apaf-1. Moreover, the Drosophila inhibitor of apoptosis protein 1 (Diap1) is required for this process. We speculate that this feedback inhibition allows cells to regulate the degree of caspase activation for apoptotic and non-apoptotic purposes.
. Their importance is evident from the fact that most apoptosis in this organism is abolished in mutants lacking these genes [6] [7] [8] [9] [10] [11] [12] . Active Drosophila caspases can be generated in vitro with dNTPs, Dronc and Apaf-1 (ref 5, 13) but broadly overexpressing Apaf-1 in developing Drosophila tissues through the engrailed (en) or armadillo (arm) promoters did not cause a significant level of apoptosis, despite a considerable level of endogenous Dronc normally expressed in these tissues (Fig. 1a, d ). The inability of Apaf-1 to trigger apoptosis correlated with the unexpected observation that Apaf-1-expressing cells had decreased Dronc protein levels (Fig. 1a, b, d ). The reduction of Dronc protein was not due to lower dronc mRNA levels, as assessed by fluorescent in situ hybridization ( Fig. 1a'' , b''). Western blot analyses of Dronc also produced similar results (Fig. 1c, d ). In healthy Schneider cells, the polyclonal anti-Dronc antibody mainly detected the proenzyme form of Dronc, as judged by its molecular weight. When these cells were stressed by treatment with a high concentration of DMSO, the antibody readily detected a faster migrating band indicative of a processed Dronc species (Fig. 1c) . We also examined Dronc protein in larval extracts. When a control protein, GFP, was ubiquitously expressed through the arm promoter, we mainly detected the proenzyme form of Dronc, as assessed by western blotting. When we attempted to activate Dronc in these larval cells by overexpressing a stable and hyperactive Apaf-1 variant (dark V   ) 14 under otherwise similar conditions, the levels of the proenzyme Dronc were reduced without generating a detectable amount of the processed Dronc band (Fig. 1d) . Conversely, we found higher Dronc levels in cells of apaf-1 loss-of-function mosaic clones within imaginal discs (Fig. 1e) . These results establish that Apaf-1 suppresses Dronc protein levels in vivo.
We also found evidence for an inverse relationship between Apaf-1 and Dronc, in which endogenous Dronc protein limits Apaf-1 protein accumulation. When dronc -/-mosaic clones were generated in discs misexpressing Apaf-1 with the en promoter, we were able to detect higher levels of Apaf-1 in many dronc -/-mosaic clones, as detected through a Myc-tag associated with the Apaf-1 transgene (Supplementary Information 1). As Apaf-1 and Dronc have been established as binding partners for cell death execution, our observations reveal an unexpected relationship between Apaf-1 and Dronc proteins in mutually suppressing each other in living cells.
As overexpression of Apaf-1 alone did not lead to apoptosis, we attempted to achieve apoptosome activation in vivo by co-expressing Apaf-1 and Dronc. These experiments were performed in eye imaginal discs using the eye-specific gene expression driver, gmr-Gal4 (Fig. 2) . Apaf-1 overexpression through the gmr promoter neither induced significant levels of apoptosis in larval eye discs, as could be detected through antibody labelling against anti-cleaved caspases, nor caused eye ablation in adults (Fig. 2a, e') . Similarly, when high levels of Dronc were induced, no significant apoptosis could be detected in larval eye discs and did l e t t e R s not cause an obvious eye ablation phenotype in adults (Fig. 1b, f ' ). By contrast, Apaf-1 and Dronc co-expression caused a significant level of apoptosis, as assessed by anti-cleaved caspase antibody labelling in eye imaginal discs and by the ablated head structure in adults (Fig. 2c, g') . Moreover, this eye ablation phenotype was completely suppressed when Diap1 was co-expressed with the apoptosome components (Fig. 2d) .
Interestingly, discs co-expressing Apaf-1 and Dronc showed lower Apaf-1 immunolabelling, compared with those eye discs in which Apaf-1 was overexpressed alone (Fig. 2e''' , g''' ). The difference in Apaf-1 labelling was particularly prominent in the posterior end of eye discs, which contain mostly post-mitotic ommatidial cells. The effect of Dronc overexpression on Apaf-1 levels was also observed using a flip-out technology that generates mosaic clones expressing genes of choice through the tubulinpromoter (see Methods). As a control, we generated mosaic clones that expressed either Apaf-1 or Dronc alone and observed large mosaic clones with high and uniform levels of these proteins (Fig. 2h, i) . By contrast, when mosaic clones co-expressing Dronc and Apaf-1 were generated, which were marked by the absence of GFP, only a small number of cells survived to form mosaic clones. But within the surviving cells, which were mostly in the posterior part of eye discs, significantly lower levels (a-g) External adult eye (a-d) and larval eye imaginal discs (e-g) expressing either Apaf-1 alone (a, e), Dronc alone (b, f) or both Apaf-1 and Dronc (c, g) through an eye-specific driver, gmr-Gal4. Co-expression of Apaf-1 and Dronc leads to adult eye ablation (c), whereas Diap1 expression rescues this phenotype (d). In all eye imaginal disc panels, Apaf-1 overexpression was detected through an associated Myc-tag (red), and Dronc protein was detected through an anti-Dronc antibody (green). Apoptosis (e', f', g') was measured using anti-cleaved caspase-3 labelling (white, indicated by arrows in g'). Co-expression of Dronc with Apaf-1 diminishes Apaf-1 labelling, particularly in posterior imaginal discs (arrow in g'''). (h-j) Expression of Apaf-1 alone (h, red), Dronc alone (i, magenta), or co-expression of Apaf-1 and Dronc (j) in mosaic clones (marked by the absence of GFP), using flipout Gal4/UAS technology. Mosaic clones co-expressing Dronc and Apaf-1 (j) survive in the posterior region of eye discs (arrow) and show decreased levels of Apaf-1 labelling (red). Scale bars represent 100 µm (a) and 50 µm (e). Genotypes: gmr-Gal4/+;UAS-apaf-1/+ (a, e), gmr-Gal4/+;UAS-dronc/+ (b, f), gmr-Gal4/+;UAS-dronc, UAS-apaf-1/+ (c, g), ey-flp;tub>GFP>Gal4/ UAS-apaf-1(h), ey-flp; tub>GFP>Gal4/UAS-dronc (i), ey-flp; tub>GFP>Gal4/UAS-apaf-1, UAS-dronc (j). l e t t e R s of Apaf-1 were detected (Fig. 2j) . This indicates that Dronc suppresses Apaf-1 and the efficiency of this suppression is particularly prominent in posterior eye discs where post-mitotic cells showed enhanced resistance to Dronc and Apaf-1 induced apoptosis.
As the primary role of Apaf-1 is to activate the catalytic activity of Dronc, we next determined whether the mutually suppressive effects Apaf-1 and Dronc require Dronc function. Through immunolabelling of wing imaginal discs, we first compared the effect of overexpressed Apaf-1 on the endogenous Dronc protein that was derived either from a wildtype allele or from a loss-of-function dronc allele (dronc
L32
), which has a missense mutation in the CARD domain 12 ( Fig. 3a) . As homozygous dronc L32-/-animals did not survive to the third-instar larval stage in which our analysis was performed, we compared the wild-type and L32 alleles when in trans over a dronc-null allele, I29 (ref. 12). Under these conditions, we found no detectable decrease in the levels of Dronc L32 protein in response to Apaf-1 overexpression (n = 10), whereas in all imaginal discs analysed containing the wild-type dronc allele, anti-Dronc immunolabelling was reduced under otherwise similar conditions (n > 50), suggesting that Dronc activity is required for its depletion (Fig. 3b, c) .
We also examined the capacity of inactive Dronc to participate in this reciprocal regulation with Apaf-1 by co-expressing the two proteins in eye imaginal discs through the gmr-Gal4 driver. When Apaf-1 levels were assessed by western blotting using imaginal disc extracts expressing various combinations of Apaf-1 and Dronc, we found that co-expression of wild-type Dronc led to a significant 15-fold reduction in the levels of the full-length Myc-tagged Apaf-1 (n = 3, P = 0.00017), compared with those expressing Apaf-1 alone (Fig. 3e) . On the other hand, a catalytically inactive Dronc transgene, Dronc C->A , did not significantly reduce Myctagged Apaf-1 levels (n = 3, P = 0.16; Fig. 3d , e). To validate the western blot analysis, we performed an immunohistochemical analysis of imaginal discs expressing different combinations of Apaf-1 and Dronc. Co-expression of wild-type Apaf-1 and Dronc yielded significantly lower levels of each protein than when each was expressed separately, but this mutually suppressive effect was not observed in a similar experiment with the Dronc C->A transgene (Fig. 3f, h ). Next, we tested whether the effect of Dronc on Apaf-1 is indirect, through the activity of effector caspases that become proteolytically active by Dronc. To determine this, we used the caspase inhibitor p35, which efficiently blocks effector caspases but does not affect Dronc 15, 16 . After analysing eight individual discs of each genotype, labelled under identical conditions, we were able to detect a significant reduction of Myc-tagged Apaf-1 in response to Dronc co-expression. The added expression of p35 together with Dronc and Apaf-1 did not affect the levels of Myc-tagged Apaf-1 protein when compared with those without p35 ( Supplementary Information, Fig. S2 ). These results indicate that the mutually suppressive nature of Dronc and Apaf-1 requires the catalytic activity of Dronc.
Caspases have been shown to cleave and destabilize Apaf-1 (ref. 14) . To test whether this cleavage site in Apaf-1 is involved in the mutually suppressive relationship between Dronc and Apaf-1, we co-expressed an uncleavable Apaf-1 mutant construct, dark V (ref. 14) , together with Dronc in eye imaginal discs (Fig. 4) . Western blot analysis to compare the levels of Myc-tagged Apaf-1 proteins in the presence or absence of . Anti-Dronc antibody is labelled in (green) and Apaf-1 was detected through its Myctag (red). (g', h') Anti-Apaf-1 single channel of discs. Both Apaf-1 and Dronc levels were low when wild-type proteins were co-expressed through the gmr promoter (g), but significantly higher levels of Dronc and Apaf-1 were detected in discs expressing the catalytically inactive Dronc, Dronc 
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Dronc co-expression showed that wild-type Apaf-1 protein was reduced significantly by approximately 10-fold with Dronc co-expression (n = 3, P = 0.00047). By contrast, we did not see a statistically significant change in the levels of the cleavage resistant Apaf-1 (dark V ) protein in the presence or absence of Dronc misexpression (n = 3, P = 0.6686; Fig. 4b, c) . Consistent with the western blot analysis, we were able to detect through whole-mount immunolabelling only low levels of Apaf-1 in control discs misexpressing wild type Apaf-1 (dark wt ) and Dronc (Fig. 4d ), whereas a significantly higher level of Apaf-1 was detected when the cleavage resistant Apaf-1 (dark V ) was co-expressed with Dronc under otherwise identical conditions (Fig. 4e) . Higher levels of the cleavage-resistant Apaf-1 protein led to a marked reduction in overexpressed Dronc protein levels, demonstrating that this mutant Apaf-1 had shifted the balance between the two protein components of the apoptosome. Despite their distinct effects on the relative protein levels of Apaf-1 and Dronc, the extent of eye ablation in adults expressing either wild-type or the cleavage-resistant Apaf-1 protein seemed similar ( Supplementary Information, Fig. S3 ). We suggest that the cleavage-resistant Apaf-1 protein changes the equilibrium between Apaf-1 and Dronc through feedback inhibition, but not the steady-state levels of active apoptosomes that these components generate. To make more active apoptosomes, we predict that further stabilization of both components may be required.
As Apaf-1 levels in the experiments described above were assessed through associated Myc-tags at the carboxy terminus, we independently assessed Apaf-1 protein levels with constructs that had GFP tags at their amino terminus. Specifically, we examined wild-type and mutant Apaf-1 constructs with changes that either make them resisitant to caspase cleavage (Apaf-1 V ) or that introduce a premature stop-codon, thereby mimicking the caspase-cleaved product (Apaf-1 CC ; Fig. 4f ). Transgenic UAS-GFP-apaf-1 flies, in which the wild-type and mutant Apaf-1 CC transgenes were targeted to a defined genetic locus (51D) were generated using the phiC31 integrase system 17, 18 . When these transgenes were expressed in imaginal discs through the en-Gal4 driver, we detected significantly less GFP-Apaf-1 CC protein when compared with the GFP-Apaf-1 WT protein (Fig. 4g, h) . Similarly, when these constructs were transfected into cultured Schneider cells, the cleavage resistant Apaf-1 v accumulated to the highest levels, whereas the Apaf CC protein levels were the lowest among those tested (Fig. 4i) 
C o n t r o l G F P -A p a f -1 W T G F P -A p a f -1 V G F P -A p a f -1 C C UAS-dark

lane 4). Genotypes: gmr-Gal4/+;UASdronc, UAS-apaf-1 WT /+ (d), gmr-Gal4/+;UAS-dronc, UAS-apaf-1 V /+ (e), en-Gal4/UAS-GFP-apaf-1 WT (g), en-gal4/UAS-GFP-apaf-1 CC (h).
l e t t e R s expression did not generate any phenotypes that were associated with the wild-type GFP-Apaf-1 expression: These included the ability to reduce endogenous Dronc levels when misexpressed (Fig. 4g' , h'' ), as well as the ability to trigger apoptosis when co-expressed with Dronc in the eye imaginal discs ( Supplementary Information, Fig. S4 ). Together, these data indicate that the absence of the C-terminal fragment prevents Apaf-1 from accumulating to substantial levels to exert its pro-apoptotic activity.
The Drosophila reaper, hid and grim genes are potent inducers of apoptosis and also well-established activators of Dronc 16, [19] [20] [21] [22] . The apparent difference between Diap1 antagonists and Apaf-1 in their ability to activate apoptosis prompted us to compare the effect of Apaf-1 and hid on Dronc protein levels. When Apaf-1 was overexpressed in mosaic clones, these cells had lower anti-Dronc labelling (Fig. 5a) . To assess the effect of hid, we kept the hid-expressing cells alive by co-expressing the effector caspase inhibitor p35, which does not affect Dronc function 16 . In contrast to Apaf-1 expressing clones, those expressing hid and p35 showed enhanced anti-Dronc labelling, whereas p35 alone did not (Fig. 5b, d) . Moreover, hid expression allowed Dronc and Myc-tagged Apaf-1 to coexist in cells when hid, p35, apaf-1 were co-expressed (Fig. 5c) . These results indicate that hid acts as a potent pro-apoptotic molecule by allowing Apaf-1 and Dronc to cooperate in cells.
As Diap1 is a major target of the pro-apoptotic function of hid [22] [23] [24] [25] , we examined possible physical interactions between Diap1 and the apoptosome components ( Supplementary Information, Fig. S5 ). In GST pulldowns, the wild-type and the BIR1 mutant Supplementary Information, Fig. S5c) .
To examine the functional significance of Diap1 in regulating the apoptosome components, we took advantage of the diap1 33-1s allele, an ENU mutant allele lacking the C-terminal ubiqutin ligase domain 26 . We expressed Apaf-1 in the posterior compartments of wing imaginal discs that harbour a mixture of diap1 33- 33-1s-/- ; p35 + cells were insensitive to Apaf-1 expression and did not show lower Dronc levels under otherwise identical conditions. Conversely, Apaf-1 protein detection in these cells was not affected by the presence of Dronc (Fig. 5e, f) . This indicates that the RING activity of Diap1 prevents Apaf-1 and Dronc from accumulating together in living cells.
A few distinct models have been proposed to describe the mechanism by which Diap1 ubiquitylates Dronc. First, Clem and colleagues have reported that Diap1 ubiquitylates mainly the processed, and therefore, active Dronc for ubiquitin-mediated degradation in cultured Schneider cells 27 . On the other hand, Meier and colleagues have reported that Diap1 primarily ubiquitylates the full-length, and therefore unprocessed Dronc for its inhibition, but this does not lead to a proteasome-dependent degradation 26 . Furthermore, Ciechanover and colleagues have shown that Diap1 can add ubiquitin to its substrates in a distinct configuration that is not recognized by the proteasome pathway 28 . In accounting for our observations, the Clem model may predict that Diap1 triggers degradation of processed Dronc, whereas an as yet unknown mechanism helps degrade the caspase-cleaved form of Apaf-1. On the other hand, the Meier and Ciechanover models, together with our findings that Diap1 can form a complex with Apaf-1 and Dronc, supports a model where Diap1 adds polyubiquitin chains for proteasome-degradation only to the active apoptosome complex, but not to Dronc monomers. These and other possible models remain to be validated in vivo. and Apaf-1 were co-expressed, Apaf-1 was detected together enhanced Dronc in these cells. (d) As a control, mosaic clones expressing p35 alone were generated (marked by the absence of GFP in magenta), which had no effect on endogenous Dronc labelling. (e-g) Diap1 is required for the mutually suppressive effects of Apaf-1 and Dronc. A schematic diagram of the genotypes of mosaic clones generated in the wing imaginal disc shown in f (e, e´). A merged image that labels overexpressed Apaf-1 (red) and endogenous Dronc (blue). diap1 -/-cells are marked by the absence of GFP (green) and indicated by white arrows. These cells were kept alive by expressing the effector caspase inhibitor p35 throughout the experimental domain (f). Single channel image of anti-Dronc (white) (f´), GFP (f´´) and overexpressed Apaf-1 (f´´´) are shown. Model of Apaf-1 and Dronc interaction (g). Apaf-1 and Dronc associate with each other to form an oligomeric apoptosome complex. In living cells, the activity of Diap1 directs it to a degradation pathway. In response to death signals, Diap1 antagonists reaper, hid and grim are induced and suppress the apoptosome instability, thereby allowing the execution of apoptosis. 33-1s ,FRT80, UAS-apaf-1/ubi-GFP, FRT80 (e, f).
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In conclusion, we believe that the observed relationship between Apaf-1, Dronc and Diap1 can be most simply interpreted through the following model (Fig. 5g) : in many Drosophila cell types that normally express Apaf-1 and Dronc, low levels of active apoptosome complexes are constantly generated and are quickly subjected to feedback-inhibition through degradation, instead of exponentially amplifying caspase activity and triggering unnecessary cell death. An early event in this inhibition is the proteolytic cleavage of Apaf-1 by Dronc, which destabilizes the entire Apaf-1 protein. As the Diap1 RING domain-deleted mutant abolishes the negative relationship between Dronc and Apaf-1 and triggers apoptosis, Diap1 probably acts as a ubiquitin ligase that promotes degradation of the active apoptosome. Our observation that Apaf-1 undergoes feedback inhibition contrasts with a popular view that the apoptosome is constitutively active and is not regulated in Drosophila 29 . Moreover, because Diap1 keeps apoptosome levels in check, our model explains why nearly all apoptotic events in Drosophila require the expression of the Diap1 antagonists, reaper, hid and grim.
MetHODs
Fly strains. Genes were overexpressed in Drosophila imaginal discs through the standard Gal4/UAS system 31, 32 . The loss-of-function mutant strains apaf-1 N28 (originally described as dark
, dronc I29 and diap1 33-1s have been described previously 9, 12, 26 . To analyse GFP-Apaf-1, we fused enhanced green fluorescent protein (EGFP) to the N-terminal side of either the full-length Apaf-1 coding sequence, or a truncated Apaf-1 that has a stop-codon engineered in place of amino acid 1292 (referred to as Apaf-1 CC ), subcloned into pUAST-attB and targeted to the 51D locus for insertion through the phiC31-integrase system 17, 18 .
Immunohistochemistry and western blots. All fluorescent images were obtained with a Zeiss LSM510 confocal microscope, using ×20 or ×40 objective lenses. The following antibodies were used: guinea pig anti-Dronc antibody raised against the full-length recombinant protein (1:25 for whole-mount labelling) 33 , monoclonal 9E10 (1:100 for immunohistochemistry; Developmental Studies Hybridoma Bank, University of Iowa) and rabbit anti-Myc (1:100 for tissue-labelling, 1:2000 for western blotting; Santa Cruz) antibodies for Myc-tag detection, rabbit anti-cleaved caspase-3 antibody (1:50; Cell Signaling Technologies), guinea-pig anti-Hsc3 (1:2000; ref. 34 ) and rabbit anti-GFP (1:1000 for tissue-labelling, 1:5000 for western blotting; Molecular Probes) antibodies. For fluorescent in situ hybridization, we used the Perkin Elmer TSA-Cy5 kit. For anti-Dronc western blots in Fig. 1 , Schneider cells (Fig. 1c) or whole larvae (Fig. 1d) were ground in 5% SDS-loading buffer before analysis. For anti-Myc western blots in Figs 3 and 4 , we loaded into each lane extracts prepared from forty eye-antennal imaginal discs isolated from late third-instar larvae. For quantification of western bands and whole-mount immunolabellings, we used ImageJ software (http://rsbweb.nih.gov/ij). The intensity of the band of interest was normalized with either an anti-Hsc3 band (Fig. 3) or a non-specific band with a relative molecular mass of 120,000 (M r 120K) present in the same lane (Fig. 4b) . Statistical significance was assessed using Student's t-test (two-tailed). To assess GFP-Apaf-1 levels in Schneider cell cultures, we transfected UAS-GFP-Apaf-1 constructs together with an actin-Gal4 plasmid.
Scanning electron microscopy. Standard procedures were used for sample preparation, including fixation in 2% glutaraldehyde, dehydration and drying in HMDS solvent. Gold-paladium was used to coat adult flies and images were taken at a ×180 magnification.
GST pulldown. Full-length Diap1 proteins 35 were used in this study. The mutant Diap1 proteins were derived from previously reported alleles 24 . The Dronc protein used in the in vitro binding assay was near full length, catalytically dead and has been described previously 33 . The recombinant Apaf-1 protein used corresponds to the first 1-29 amino acids and thus lacked the C-terminal WD repeats. Diap1 was labelled with GST-pull down assays between Diap1, Dronc and Apaf-1. (A) GST-Diap1 wild type protein pulls down His-tagged Dronc. This interaction is seen with GSTDiap1 6-3s protein, which has a missense mutation in the BIR1 domain; but is not seen with GST-Diap1 23-4s protein, which has a missense mutation in the BIR2 domain. Dronc was detected through an anti-Dronc immunoblot.
The input lane shows 50% of the Dronc protein used in the GST pull down experiments. (B) GST-Apaf-1 does not pull down 35 S-Diap1 directly, but interacts in the presence of His-Dronc. 35 S-Diap1 was detected through autoradiography. The input lane shows 10% of the Diap1 protein used in the actual pull downs. (C) A schematic diagram of the predicted Diap1/Dronc/ Apaf-1 complex based on the GST pull down experiment.
Figure S5
Full scans of gel data.
